<DOC>
	<DOCNO>NCT01919606</DOCNO>
	<brief_summary>The primary objective study determine optimal two different volume EXPAREL 266 mg administer via infiltration transversus abdominis plane ( TAP ) prolong postoperative analgesia subject undergo open total abdominal hysterectomy .</brief_summary>
	<brief_title>EXPAREL Administered Into TAP Analgesia Subjects Undergoing Open Total Abdominal Hysterectomy</brief_title>
	<detailed_description>This prospective , open-label , non-randomized study two treatment group differ volume EXPAREL infiltrate TAP . All subject undergo open total abdominal hysterectomy . The dose EXPAREL TAPs 20 subject , 133 mg right side abdomen 133 mg leave side abdomen .</detailed_description>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<criteria>Females , 1875 year age inclusive . American Society Anesthesiologist ( ASA ) physical status 13 . Undergoing open total abdominal hysterectomy ( i.e. , laparoscopic procedure sufficient ) without concurrent surgical procedure ( ) . Physically mentally able participate study complete study assessment . Able give fully inform consent participate study demonstrate good understanding risk benefit TAP . Demonstrated hypersensitivity idiosyncratic reaction amidetype local anesthetic . Any subject whose anatomy , surgical procedure , opinion Investigator , might preclude potential successful performance TAP . Any subject opinion Investigator might harm poor candidate participation study . Any subject , opinion Investigator , chronic pain medicine . Subjects received investigational drug within 30 day prior study drug administration , plan administration another investigational product procedure participation study .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>hysterectomy</keyword>
	<keyword>analgesia</keyword>
</DOC>